News from Alzheimer's Disease
Stay current with all the latest and breaking news about Alzheimer's Disease, compare headlines and perspectives between news sources on stories happening today. In total, 450 stories have been published about Alzheimer's Disease which Ground News has aggregated in the past 3 months.
Covered Most By
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Alzheimer's Disease News
Latest News Stories
Alzheimer · PakistanThe European Union’s drugs regulator has rejected Eisai and Biogen’s Leqembi treatment for early Alzheimer’s disease, saying the risk of serious brain swelling did not outweigh its small impact on slowing cognitive decline. The decision, released on Friday, is a blow to the companies as the drug faces slow take-up in the United States. Biogen’s shares fell 5% to $216.28 in early US trading. Eisai and Biogen said they will seek re-examination of …See the Story
Leqembi: Alzheimer's drug from Eisai and Biogen faces setback
Alzheimer's DiseaseScientist comment on the EMA decision on the use of lecanemab for Alzheimer’s disease. Prof Jonathan Schott, Chief Medical Officer at Alzheimer’s Research UK, said: “Lecanemab is not a cure for Alzheimer’s disease, but evidence from clinical trials suggests that it can slow progression in people with mild forms of the disease, in whom it leads to benefits in quality of life and reduces impact on carers. “While it is of course vital to balance…See the Story
expert reaction to EMA decision on lecanemab for Alzheimer’s disease
Alzheimer · SwedenThe marketing authorization application for lecanemab, a drug for the treatment of Alzheimer's disease, receives a negative recommendation from the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency. This is reported by the Swedish pharmaceutical company Bioarctic in a press release. The drug is based on a discovery by the Swedish researcher La...See the Story
Alzheimer's drug gets no
Alzheimer · CambridgeResearchers from MIT conducted an extensive study on Alzheimer’s disease, analyzing gene expression in various brain regions to understand why specific cells and circuits are vulnerable. The study identified neurons in the hippocampus and entorhinal cortex as particularly susceptible due to reducSee the Story
The Battle Within: MIT Unveils Genetic Keys to Alzheimer’s Resilience and Vulnerability
100% Center coverage: 1 sources
